We have located links that may give you full text access.
The Role of Aversive Appearance-Related Comparisons and Self-Discrepancy in Depression and Well-Being From a Longitudinal General Comparative-Processing Perspective.
Behavior Therapy 2024 May
Research indicates that aversive appearance-related comparisons (i.e., perceived as threatening one's own motives) are associated with depressive symptoms. However, central elements underlying the comparison process are poorly understood. Drawing on central propositions of comparison theory, we hypothesized that an increased aversive comparison frequency instigates high levels of perceived comparison discrepancy to the standard, resulting in an intensified negative affective impact. Consequently, this heightened affective impact is expected to elicit more depressive symptoms and lower psychological well-being. We additionally expected that these pathways are moderated by dispositional self-discrepancies. In a two-wave longitudinal study, participants with elevated depressive symptoms (N = 500) responded to measures of self-discrepancy, depressive symptoms, psychological well-being, and the Comparison Standards Scale for Appearance. The latter assesses aversive social, temporal, counterfactual, and criteria-based comparisons regarding their frequency, perceived discrepancy to the standard, and engendered affective impact. The affective impact after engaging in aversive appearance-related comparisons (partially) accounted for the relation between comparison discrepancy and subsequent depressive symptoms and psychological well-being. Perceived discrepancy to the aversive comparison standards was not a key variable in this process. Dispositional self-discrepancy emerged as moderator on different pathways. Clinical implications are discussed in light of central theoretical accounts from a general comparative-processing perspective.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines.Chest 2024 March 5
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app